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Abstract
Background: Recent reanalysis of spike-in datasets underscored the need for new and more accurate benchmark
datasets for statistical microarray analysis. We present here a fresh method using biologically-relevant data to
evaluate the performance of statistical methods.
Results: Our novel method ranks the probesets from a dataset composed of publicly-available biological
microarray data and extracts subset matrices with precise information/noise ratios. Our method can be used to
determine the capability of different methods to better estimate variance for a given number of replicates. The
mean-variance and mean-fold change relationships of the matrices revealed a closer approximation of biological
reality.
Conclusions: Performance analysis refined the results from benchmarks published previously.
We show that the Shrinkage t test (close to Limma) was the best of the methods tested, except when two
replicates were examined, where the Regularized t test and the Window t test performed slightly better.
Availability: The R scripts used for the analysis are available at http://urbm-cluster.urbm.fundp.ac.be/~bdemeulder/.
Background
Objectives
The sensitivity of microch i pd a t aa n a l y s i st o o l si s
strongly limited by the weakness of the estimation of
variance because the number of replicates is generally
low and variance heterogeneity is high. Several methods,
variants of the classical t test [1], have been developed
in recent years to increase this sensitivity by improving
the estimation of variance. These methods are generally
benchmarked on artificial “spike-in”) or simulated data.
Consequently, the ability of the methods to better esti-
mate variance is tested only on technical or modelled
variances, and not on biological variance. We propose
to evaluate these statistical strategies on actual biological
data in order to avoid this bias. As the use of actual data
does not allow for definition of the unambiguous “truth”
to identify true and false positives, we propose a novel
approach to circumvent this limitation.
State of the art
Microchip data analyses are confronted with the double-
edged problem of multiple testing and weak variance
estimation due to the often limited number of replicates.
Furthermore, departure from normality and variance
heterogeneity between genes and between experimental
conditions for a given gene can decrease the confidence
of statistical tests. Moreover, data has shown that a non-
trivial mean-variance relationship benefits to methods
analyzing groups of genes [2,3] instead of analyzing
genes separately. This relies on the fact that n genes
sharing similar expression levels also share more similar
variances than n genes sampled randomly.
Aside from the classical Welch correction for variance
heterogeneity [4], numerous heuristics have been devel-
oped over recent years to improve the estimation of var-
iance and consequently the statistical power of the tests.
The Window t test, Regularized t test and LPE test
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expression level. SAM, the Regularized t test and Mod-
erate t test (Limma) use an empirical Bayes model to
estimate the variance [2,6,7]. The Moderate t test and
two versions of a shrinkage approach base the estima-
tion of variance on distributional assumptions [7-9].
Table 1 shows the variance shrinkage used in different
heuristics (Regularized t t e s t ,S A M ,M o d e r a t et and
Shrinkage t). The general formulation of the variance
estimator can be written: V = a V0 +bV g. Thus, the
variability estimator is estimated from two terms,
respectively background variability V0 and individual
variability Vg. Those terms are first used either to com-
pute a sum (SAM) or a weighted average value (Regular-
ized t test, Moderated t, Shrinkage t). This is operated at
the variance level, except in the SAM procedure where
the offset term is added at the level of the standard
deviation.
In the Regularized t test procedure, an arbitrary para-
meter is used to weight this mean value, based on the
number of replicates (n + n0 = k = arbitrary value = 10
in the original procedure, where n is the number of
replicates and n0 is the number of “virtual replicates”
used to compute the background variance). Limma also
uses the degrees of freedom associated with each varia-
bility term as weighting factors. The degrees of freedom
associated with background variance are computed from
the expression data matrix, considering a mixture of
genes with and without differential expression.
To compute the Shrinkage t statistic, those terms are
weighted according to the minimum value between one
and an intermediate statistic reflecting the dispersion of
individual estimates compared with their deviation from
the median value.
Another diverging aspect of the procedures is estima-
tion of the correction term used to shrink variance
towards an optimal value. The background term is com-
puted using different procedures: (i) from a relationship
between expression level and variability (Regularized
t test), (ii) from the value minimizing the dispersion of
the Student t derivate statistic (SAM), (iii) from a math-
ematical model describing the mixture of two sets of
genes (Moderated t), and from the median value of the
individual variance distribution (Shrinkage t).
Using their own variance estimates, each method
computes a t statistic, either based on equal variances
(SAM, Moderated t,S h r i n k a g et) or unequal variances
(Regularized t test, Shrinkage t). The significance of
each statistic is then assessed by comparison with a null
distribution, in accordance with the model: (i) the t dis-
tribution with degrees of freedom computed following
Welch’s correction (Regularized t test), (ii) from the
cumulative distribution associated with the 2 sets of
genes, with corrected degrees of freedom (Moderated t),
or (iii) empirically from permutations of sample labels
(SAM). The Shrinkage t procedure does not include a
null distribution and only uses the t-like statistic to rank
the results.
Table 1 Summary of variance shrinkage used by several procedures
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The general formulation V = a V0 +bV g illustrates that the variability estimator is estimated from two terms, respectively the background variability V0 and
individual variability Vg.
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way in which the variances and/or their degrees of free-
dom are computed. Paradoxically, the datasets available
to compute the rates of false positives and negatives and
thus evaluate the sensitivity and specificity of each
approach are based on simulated or spike-in data. Such
data is characterized by variances, variance heterogene-
ities and mean-variance relationships which differ from
those actually observed with biological data. The pro-
blem when benchmarking these methods is precisely the
discrepancies between the data used and the perfor-
mances allegedly tested.
Existing benchmark datasets
Over recent years, we have witnessed the emergence
of a huge number of pre-processing and processing
methods for microarray analysis. To validate these
approaches and compare their performances, we need
datasets for which both non differentially-expressed
genes and truly differentially-expressed genes (DEG) are
known. Up to now, this question has been addressed by
spike-in experiments or in silico simulations.
a - Spike-in datasets
A spike-in experiment is a microarray experiment where
RNA is added in known quantities. A few datasets of
this type are available, namely the two Latin Square
datasets from Affymetrix [10] and the “golden spike”
experiment [11]. These datasets were used in several
papers to compare methods that analyse differential
expression in microarray experiments [12-15]. However,
the results appear to be highly dependent on the dataset
chosen to test the methods, which can be explained by
the extremely divergent characteristics of these datasets.
The Affymetrix Latin Square datasets are character-
i z e db yav e r yl o wn u m b e ro fd i f f e r e n t i a l l y - e x p r e s s e d
genes (42/2230 genes, about 0.2% of all genes, in the
HG-U133 Latin Square), an extreme fold-change range
(from 2 to 512) and a large concentration range (from
0.125 pM to 512 pM in the HG-U133 Latin Square). In
these datasets, a complex human RNA mixture (human
cRNA from the pancreas in HG-U95) was added under
all experiment conditions to mimic the bulk of non dif-
ferentially-expressed genes.
Choe’s spike-in dataset [11], made with a Drosophila
chip, was designed to compensate for the failings of
existing datasets, and differs considerably from the Latin
Square datasets on a number of points: (i) the propor-
tion of spiked DEGs is high, about 10% of all genes;
(ii) RNA was spiked in high quantities (iii) only up-regu-
lated genes were included in the dataset, which is not
expected in real experiments; (iv) no unrelated back-
ground RNA was used, but an important number of
genes were spiked in equal quantities on all arrays. This
made it possible to distinguish between empty genes,
and genes expressed with no differential expression. In
Affymetrix’s Latin Squares, the complex and undefined
background RNA eliminated the possibility to distin-
guish between unexpressed and expressed genes.
The aim of spike-in datasets is to mimic a typical
microarray experiment, and their main problem is deter-
mination of parameters such as the proportion of DEGs
and their concentration, the up- or down-regulation of
genes, the amount of the mixture that is added to
mimic the bulk of equally-expressed genes. However,
these parameters influence the results as well. For exam-
ple, the proportion of DEGs influences the normaliza-
tion procedure, which assumes that the majority of
g e n e sa r en o td i f f e r e n t i a l l ye x p r e s s e d ,b u ti tc a n n o tb e
defined from actual experiments where this proportion
remains unknown. Each one of the two available types
of spike-in datasets has dramatic biases, and re-analyses
have been performed on Choe’s dataset to take them
into account [12,13,15].
Performances can be compared together on both data-
sets considered as two extreme but imperfect conditions.
Then the “best” combination of pre-processing and pro-
cessing would be that which provides the best perfor-
mance in both tests. However, this pragmatic approach
does not lead to an improved understanding of the under-
lying mechanisms and parameters which make a method
perform better than another under given conditions.
Moreover, biological variance is not taken into account, as
both datasets contain only technical replicates.
b - Simulation datasets
Some authors have tried to model in silico microarrays.
Among others, Parrish et al [16] and Singhal et al [17]
attempted to model the complex reality of a microarray
on the basis of observation or real datasets.
The first study was based on a multivariate normal
distribution (by selecting mathematical transformations
of the underlying expression measures such that the
transformed variables approximately follow a Gaussian
distribution, and then estimating the associated para-
meters) in order to model transformed gene expression
values within a subject population, while accounting for
co-variances among genes and/or probes. This model
w a st h e nu s e dt os i m u l a t ep r o b ei n t e n s i t yd a t ab ya
modified Cholesky matrix factorization [16].
Though Singhal’s general approach might appear to be
similar to ours as it is also based on real datasets, his
method differs in the fact that he extracted parameters
(biological and technical variance) from these datasets
to simulate datasets based on the parameters [17], while
we use the data itself. Like all simulated datasets,
numerous simplifications are made and skew reality. So,
Parrish et al approximated Gaussian distributions and
Singhal et al approximated biological and technical var-
iance using mathematical equations, which inevitably
skews or impoverishes reality.
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trix Latin Squares and Golden Spike experiments), over-
expression is simulated by the addition of RNA fragments
at known concentrations, with great reproducibility
between the replicates [13]. Important biological variability
observed in real datasets is completely eliminated. When
the truth is simulated in silico [16,17], classical biases gen-
erated by the simplification of modeling are expected.
The classification of statistical methods thus reflects
their ability to detect true positives and avoid false nega-
tives in an artificial context, which is in obvious contra-
diction with the fact that methods differ primarily in
their approach to the estimation of variance. The relia-
bility of these benchmarks is thus open to discussion at
the very least. A biological microarray dataset for which
the truth is known simply does not exist.
Methods
Strategy proposed
The goal of our approach was to benchmark different
statistical methods on authentic biological data in order
to preserve the actual mean-variance relationship. The
“truth” is not inferred by simulation or induced by spike-
in of a known concentration of genetic material. Different
sets of genes are defined as the truth, designed to be
more or less difficult to isolate from the background.
We selected the genes from archived experiments on
at least 15 replicates under two experimental conditions
on one same platform (Affymetrix’s HG-U133a). This
number of replicates represented a good compromise
between dataset availability and variance estimation
quality. Indeed, when n = 15, the difference between the
Z and t distributions is very slight.
The “truth” is defined as a set of genes characterized
by a predetermined ratio between differential expression
and variability between replicates. This ratio is com-
puted such that under optimal conditions (normality,
homoscedasticity and known variance) the classical t
test would be characterized by a given sensitivity and a
given positive predictive power (see below: theoretical
background). The sensitivity and positive predictive
power are then fine-tuned to render genes increasingly
difficult to distinguish from the background. The cap-
ability of the various statistical methods to detect these
sets of genes is then tested on a limited subset of repli-
cates selected at random from among those used to
define “the truth”.
Thus, the benchmark does not compute false positive
and negative rates in comparison with an experimen-
tally-validated “truth” - which is unrealistic - but tells
that, if the “truth” were to be this set of genes, the per-
formances of the methods would be those evaluated.
Several problems are circumvented using this approach
such as: (i) the fundamental problems of respect of actual
biological variance, the respect of the dependence of this
variance on the level of gene expression, the difference in
variance between genes as well as between control and
test replicates are addressed by collecting actual experi-
mental data, (ii) the prevalence of differentially-expressed
genes, often limited in spike-in data (0.2% DEGs in the
Latin Square datasets), is controlled and kept constant by
re-sampling in over 1,000,000 DB-probesets (we call one
row of the DB matrix a “DB-probeset” to avoid confusing
with an original probeset (in any classic expression set))
obtained through the combination a large number of
datasets, (iii) uneven detection efficiency due to a mix of
extreme fold change in a same benchmark (from 2 to 512
in the Latin Square datasets) is avoided by defining more
homogeneous differentially-expressed sets of genes. This
means that methods are evaluated for a given detection
limit and not for a mix of genes in which some are trivial
and some are too difficult to detect.
Finally, a non-trivial problem addressed here is that
the variation of the number of replicates influences the
statistical power both through variance estimation qual-
ity and the magnitude of the standard error. We fine-
tuned the ratio between differential expression and
variability according to the number of replicates (n) (the
higher the n, the lower the ratio) so that the difficulty to
find a set of genes considered as the truth would remain
constant if the variance were known. The effect of n on
variance estimation quality can thus be strictly isolated
and improvements in the estimation of variance can be
evaluated in detail.
Theoretical background
The positive predictive power (PPP) of a test is defined
as a function of the numbers of true positives (TP) and
false positives (FP) according to Equation 1.
PPP
TP
TP FP
=
+
(1)
L e tPb et h ep r e v a l e n c eo fo v e r -o ru n d e r - e x p r e s s e d
genes, a the probability of type I error and b the prob-
ability of type II error. Equation 1 can be transformed
to express PPP as a function of (1-b), a and P (Equation 2)
and, from there, a as a function of (1-b), P and PPP
(Equation 3) [18].
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Let n be the number of replicates (considered constant
along a procedure), s
2 t h ev a r i a n c ec o n s i d e r e da s
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expression under conditions 0 and 1. n can then be
expressed as a function of power (1-b) and confidence
(1-a) according to Equation 4 [18].
n
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−
()
()
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2 2
01
2
 
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Let D = M0-M1, the estimation of μο-μ1of variance 2 s
2
and S the estimation of s. The ratio D/Sthreshold expressed
in Equation 5 is directly related to the ability of the Stu-
dent t test to detect a given differential expression on n
replicates with power (1-b) and confidence (1-a).
D
S
ZZ
n threshold
=
− + − 2 11  (5)
As D/Sthreshold is computed from 15 replicates, it pro-
vides a rather good estimate of μ0 - μ1 and s. It approx-
imates the limit for rejecting Ho under ideal conditions
(normal distribution and homoscedasticity) with the
Student t test at a given n, power and confidence.
T w om a i nq u a l i t i e so fat e s tm a yb ec o n s i d e r e dt ob e
its sensitivity (1-b) and positive predictive power (PPP)
(Equation 1 and 2). When high, these probabilities
ensure that the user will find an important part of the
truth, with low random noise, respectively.
In our benchmark, we fixed the number of replicates
for subsets of replicates (n), prevalence (P), sensitivity
(1-b) and positive predictive power (PPP). The value of
a is deduced from Equation 3 and the corresponding D/
Sthreshold computed from Equation 5. This allows us to
define a subset of genes which is more or less easy to
detect from the background, and to keep this difficulty
constant when increasing n to improve the quality of
the variance estimate.
Implementation
Data collection (cel files)w a sp e r f o r m e du s i n gG e n e
Expression Omnibus [19] on the Affymetrix platform
HG-U133a (Human Genome model U133a). This collec-
tion consists of 34 datasets (table 2) for which there are
at least 15 replicates for each of 2 different experimental
conditions. With all the cel files from one experiment, we
built an Affybatch object, which is simply a structured
concatenation of the files. These 34 Affybatch objects
were pre-treated using the R package GCRMA [20]. As
the benchmark is tested gene by gene, a pre-treatment
including all Affybatch objects globally was not needed.
Giant datasets (e.g., GSE3790 with 202 replicates in
three different brain regions) were first split into subsets
according to their biological content. The datasets were
then sampled as follows: when the number of replicates
was ≤ 29, 15 replicates were selected randomly. When the
number of replicates was ≥ 30, 15 replicates were selected
randomly a first time, and a second time in the remaining
replicates, and so on for 45, 60 replicates or more.
The resulting “Expression sets” were appended in a sin-
g l em a t r i x( n a m e dD Bb e l o w )o f2×1 5c o l u m n s( r e p l i -
cates) collecting 1,292,414 lines (DB-probesets). The D/S
ratio was computed for each DB-probeset, where D is the
difference between the means and S is the square root of
the mean variances under the two experimental condi-
tions. The matrix DB was sorted according to the |D/S|
value, from the top corresponding to the most over- or
under-expressed genes (relative to their standard error) to
the bottom corresponding to non differentially-expressed
Table 2 Datasets list
Dataset Number of replicates
GSE10072 107
GSE10760 98
GSE1561 49
GSE1922 49
GSE3790FC 65
GSE3790CN 70
GSE3790CB 54
GSE3846 108
GSE3910 70
GSE3912 113
GSE5388 61
GSE5392 82
GSE5462 116
GSE5580 42
GSE5847 95
GSE646-7 93
GSE643-5 126
GSE648-9 125
GSE650-1 122
GSE6613 105
GSE7670 53
GSE7895 104
GSE8401 83
GSE8835 65
GSE8397 47
GSE9676av-ap 60
GSE9676m-f 60
GSE9676m 30
GSE9676f 30
GSE9716 38
GSE9874b-f 60
GSE9874 60
GSE9877 47
GSE994 75
Datasets used for construction of the initial matrix. The number of replicates
is the number of microarrays in the experiment.
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times from DB as follows: the dimensions were set at
20,000 DB-probesets and 2 × n replicates to correspond
roughly to an actual expression set (figure 1). The preva-
lence which was defined at 1% (200 DB-probesets) is a
compromise between enough genes to accurately compute
frequencies of true and false positives and not too much
to get a relative homogeneity of D/S in the set. Inciden-
tally, this prevalence is in the order of magnitude of cur-
rent lists of expected genes of interest in many biological
contexts.
For a relative evaluation of the statistical methods, the
D/Sthreshold was moved according to the increase of n,
such that the difficulty to find a set of genes considered
as the truth would remain constant if the variance were
known. For a given set of parameters n, PPP and (1-b),
the D/Sthreshold was computed and the 200 genes above
the limit were selected in DB and considered as the target
genes (true positive). A second D/Sthreshold was computed
to correspond to 0.9 × (1-b) and 19,800 genes considered
as the background (the true negative) were selected ran-
domly in DB, under this limit. The genes in the “twilight
zone” between the two limits were not considered to
avoid an abrupt transition between both gene statuses.
Finally, to evaluate the absolute performance of the
best statistical methods, the D/S threshold was com-
puted for n = 2 and for given combinations of PPP and
(1-b), thus defining the “truth” constant for every set of
subset matrices for the run considered; five subset
matrices of 15 replicates - instead of two - were
generated as describe above and resampled for n = 2, 3,
up to 10 such that the difficulty to find a set of genes
considered as the truth increased according to n, due to
the combined effect of improved variance estimation
and reduced standard error.
Each subset matrix was treated using the PEGASE
software developed in our laboratory (Berger et al.,
CEJB, under revision). Briefly, several differential expres-
sion analysis methods were implemented from scratch
and gathered in the R package called PEGASE. Among
the methods currently implemented for differential
expression analysis are the classic Student t test [1] and
Welch correction for heteroscedasticity [4], SAM [6],
Regularized t test [2], Window t test [3]. The package
includes a performance evaluation of the methods
implemented when a list of truly differentially-expressed
genes is provided. Limma [7] and Shrinkage t [9] are
not yet implemented in PEGASE and were downloaded
and run stand-alone.
For each combination of parameters and statistical
analysis, we computed the observed power, or sensitivity
(Equation 6) and the false positive rate (Equation 7) for
five samples for increasing values of a, step by step.
Sensitivity
TP
FN TP
=
+
(6)
FPR
FP
TN FP
=
+
(7)
D/S Control Test
15 columns 15 columns
1,292,414 lines
Twilight   zone D/S threshold 1
D/S threshold 2
D/S Control Test
1 to 15
columns
1 to 15
columns
200 lines
19,800
lines
D/S Control Test
1 to 15
columns
1 to 15
columns
200 lines
19,800
lines
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O
R
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Figure 1 General sample design. Left panel: matrix DB, appending 34 datasets. Computation of two D/Sthreshold ratios (see text) determines
different zones in the matrix. The light grey zone contains DEGs and is integrated to the subset matrix (right panel) as such. The dark grey zone
contains the non DEGs. 19,800 rows are selected randomly within this zone to form the background of the subset matrix. A twilight zone
segregates the DEGs from the non DEGs.
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n and runs) was run over the five random samplings of
replicates in DB, on the sensitivity computed for 1%
FDR. This ANOVA produced a residual mean square
(RMS) value corresponding to the error term of each
fixed effect. This RMS was used in post-hoc compari-
sons performed for pairwise comparisons of the meth-
ods [21] and for comparisons of each method with the
reference method [22].
Algorithm
The input used in the algorithm which computed the
performance curve coordinates (FDR, Sensitivity, and
Specificity) was the full list of p values for each method.
As each list of p values does not cover the same range
of values, we needed to use the minimum significance
value to define the starting point of the procedure.
Moreover, as the beginning of the curves is the most
informative, corresponding to small p values, we decided
to define each step from regular progression at the loga-
rithm of p values. The pseudo-code of the algorithm
used is described below:
1) Retrieve the minimum p value (min.pval);
2) Compute the logarithm of this minimum value
(log.min.pval), with base = 10;
3) Compute log.int = vector with 1000 values defin-
ing regular intervals between log.min.pval and 0
(corresponding to the maximal p value = 1);
4) Compute the final list of values defining the inter-
vals (int), using int = 10^log.int;
5) For each value in int, compute FDR, sensitivity,
specificity from each list of method-specific p
values.
Results
Mean - Standard deviation relationship
Figure 2 illustrates the empirical relationship between the
average expression level and standard deviation. Figure 2A
represents the relationship observed for the total
benchmark dataset. Figure 2B shows the corresponding
plot obtained from a subset of the total biological bench-
mark dataset. Finally, figure 2C presents an example of the
same graph generated on a biological dataset (E-MEXP-
231 from Array Express) [23,24] which was not included
in the creation of the benchmark dataset.
Interpreted together, the plots shown in figure 2 reveal
that the design of the Biological Benchmark from real
datasets (2 A) leads to a similar expression level/variabil-
ity dependence compared with real datasets (2 C). The
definition of subsets based on the D/S statistic com-
bined with the positive predictive value and power para-
meter generates datasets with properties which are
similar to real datasets (2 B).
MAplot
A MAplot represents the average log expression versus
the average ratio between conditions. Figure 3C shows
the MAplot obtained from the same dataset used for
figure 2[23], after pre-processing (GCRMA). As can be
seen in the figure, points are typically widely distributed
along the X-axis while being centered around M = 0 on
the Y-axis. Figures 3A and 3B show the MAplots from
our total benchmark dataset and a subset thereof. The
similarity between these two figures and figure 3C high-
lights that our dataset distributions are close to a real
dataset distribution. In comparison, MAplots obtained
from spike-in datasets clearly show their biases, espe-
cially the extreme fold changes of the Latin Square
LS95, and the absence of down-regulated DEGs in the
Golden Spike Experiment dataset (LS95, LS133: [10,11]).
Volcano plots
Different sets of parameters were tested and those retained
here are the most typical, intermediate values which pro-
vide intermediate results. Four runs were performed for
increasing difficulties to find the target DB-probesets. For
run 1 (PPP = 0.99 and sensitivity = 0.99), the true positives
were easy to find and there was little noise. For run 2
(PPP = 0.5 and sensitivity = 0.99), the true positives were
easy to find and there was more noise. For run 3 (PPP =
Figure 2 Mean versus sd plots. Standard deviation versus mean expression level. a) total benchmark dataset; b) subset of the total biological
benchmark dataset; c) biological dataset (EMEXP-231). The dark grey curves represent the medians of the values and the light grey curves
represent quartiles (median ± 25%).
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to find but there was less noise. And for run 4 (PPP = 0.5
and sensitivity = 0.5), the true positives were difficult to
find and there was more noise.
Volcano plots present the DB-probesets in a graph of
p values according to a given statistical test versus fold
change. In the present context, they represent the
increasing difficulty to find true positives through runs
(figure 4). Typically, interesting features are located in
the upper left and right corners of the graphs, as the
fold change values (X axis) and p values (Y axis) exceed
the usual thresholds used for analysis.
Volcano plots were drawn for the four runs with the
Student t test with three replicates. On 200 DEGs, in
run 1, nearly one half (92) of the target DB-probesets
(black points) had a p value lower than 10
-2 and the
average fold change was -1.19 ± 4.1 (M ± 2 s.d.). As
expected, in run 2, fewer target DB-probesets were
found to be significant (44) and the average fold change
was -0.29 ± 3.82. In run 3, most of the target DB-
Figure 3 MAplots. A MAplot represents the average log expression versus the average ratio (or fold change) between two conditions. a) total
benchmark dataset; b) subset of the total biological benchmark dataset; c) biological dataset (EMEXP231).
Figure 4 Volcano plots. Volcano plots show the -log10 (p-values) versus the log2(fold change). In black, the DEGs, in grey, the non DEGs. The
horizontal line represents the 10
-2 threshold on the p values, while the vertical lines show thresholds of ± 2 fold changes. From a) to d) (runs 1
to 4), the difficulty of finding DEGs increases.
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Page 8 of 14probesets did not exceed the significance threshold of
10
-2 (29) and the average fold change was -0.147 ± 3.44.
Finally, under the most difficult conditions (run 4), only
few target DB-probesets still exceeded the statistical
thresholds (12) and the average fold change was -0.006 ±
1.96. Surprisingly, as revealed by the negative mean
value, most of DEGs were down-regulated, but this fact
will not have an impact on our results.
Relative performances of the statistical methods
Figures 5 and 6 show the change in sensitivity for all
(figure 5) or a selection (figure 6) of the methods studied.
They present a summary of the information from all of
the ROC curves for all n, taken at a FPR equal to preva-
lence (1%). This value was chosen because ROC curves
become non-informative when the FDR exceeds the pre-
valence [25]. For more details, see additional file 1.
Run 2 (figure 5) is illustrated for all of the methods tested.
As the Shrinkage t and Limma on one hand and the Regu-
larized t test and Window t test on the other showed only
slight differences between them, only a selection of
methods is displayed for purposes of clarity in figure 6 for
Runs 1, 3, and 4, with the Student t test as the reference.
Though it has become obvious that the Shrinkage t is
most often the best method, we show that, when there
are only two replicates, the Regularized t test and Win-
dow t test are better. We also observed that when they
a r e1 0o rm o r er e p l i c a t e s ,t h ec h o i c eo ft h em e t h o d
becomes less important, as all of the methods perform
quite equally.
A ranking of the methods is presented in table 3 for all
runs and number of replicates (rank 1 being the best).
We only show statistical differences found by Dunnet’s
post hoc comparison with p ≥ 0.05. We could not high-
light any significant difference for run 4. Across all of the
statistically relevant data, the Shrinkage t appears to have
the lowest mean ranking. It shall therefore be considered
as the reference method from now on. However, we
noted a striking change between 2 and 3 or more repli-
cates: the Regularized t test and Window t test appear to
have the best performances only for n = 2.
Figure 5 Relative performances of the methods. Relative performances of the methods. Sensitivity versus number of replicates for statistical
methods (GCRMA as pre-treatment, run 2, FPR and prevalence = 1%). Except for two replicates, the Shrinkage t performs the best. For 10 or
more replicates, SAM and the Regularized t test are as efficient.
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To assess the absolute performances of the methods
tested, we performed a new test such that the difficulty
to find a set of genes considered as the truth increases
according to n, due to the combined effect of improved
variance estimation and r e d u c e ds t a n d a r de r r o r( s e e
Implementation).
The ranking of the three methods presented is the
same as before: the Shrinkage t is better overall, except
for n = 2, where the Regularized t test (superimposed to
Window t test, data not shown) is slightly better. More-
over, this figure presents the maximal performances of
the methods with respect to the run considered, as the
truth defined for two replicates is the easiest to recover.
For Shrinkage t, in a gene list where 1 false positive is
expected for 1 true positive, 80% of sensibility is
expected for the run 1 with n = 3 when the fold change
is -1.234 ± 4.42, for the run 2 with n = 4 when the fold
change is -0.812 ± 4.5, for the run 3, with n = 7 when
t h ef o l dc h a n g ei s- 0 . 4 6±3 . 8 6a n df o rr u n4w i t h
n > 10 when the fold change is -0.013 ± 2.3.
Discussion
Our benchmark dataset is difficult to objectively com-
pare with previously published benchmarks because we
used a different approach, where the definition of the
truth was not so straightforward and irrefutable but
actual variance was conserved.
Figure 6 Sensitivity versus number of replicates.S e n s i t i v i t y
versus number of replicates for classic Student t test, Shrinkage t,
Limma and Regularized t test. From top to bottom: run 1, run 3 and
run 4 (DEGs increasingly difficult to find). Except for two replicates,
Shrinkage t performs the best. For two replicates, Regularized t test
performs best.
Table 3 Ranking of the performances
RUN 1
n 2 3 4 6 8 10 Average
Student 7 7 5 5 5 5.8
Window 2 6777 5 . 8
Welch 8 8 6 6 6 6.8
Win Welch 5 5 8 8 8 6.8
Reg t test 1 3443 3 . 0
SAM 6 4 3 3 2 3.6
Limma 4 2224 2.8
Shrinkage t 3 1111 1.4
RUN 2
N 2 3 4 6 8 10 Average
Student 7 7 6 5 4 5.8
Window 2 6565 4 . 8
Welch 8 8 8 7 7 7.6
Win Welch 3 5 7 8 8 6.2
Reg t test 1 3 2 4 6 3.2
SAM 6 4 4 3 1 3.6
Limma 5 2 3 2 3 3.0
Shrinkage t 4 1112 1.8
RUN 3
n 2 3 4 6 8 10 Average
Student 8 8 5 7.0
Window 2 5 6 4.3
Welch 7 7 8 7.3
Win Welch 3 4 7 4.7
Reg t test 122 1.7
SAM 6 6 4 5.3
Limma 5 3 3 3.7
Shrinkage t 4 11 2.0
Ranking of the performances of all the methods tested. Only significant
differences (DUNNET’S post hoc comparison p ≥ 0.05) for each method with
respect to Shrinkage t are displayed (no significant difference in Run 4). 1
st
and 2
nd ranks are shown in bold.
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truth introduces a bias towards t-like statistics. This is
w h yw eo n l ym e a s u r ep e r f o r m a n c e sf o rs u c hm e t h o d s .
As for methods in specific, we think that this bias does
not change their ranking.
For example, the Limma method may be favored by
this bias as it relies on the existence of two different dis-
tributions (DEG and non-DEG) and the benchmark cre-
ates those two distributions using a twilight zone. Thus,
the Limma method’s performances should be better
than those of Shrinkage t test, globally based on the
same principles but not using a pre-defined distribution.
However, we show that the Shrinkage t performs slightly
but significantly better than Limma.
In the Golden Spike Experiment [11], the authors
compared the Regularized t test with the Student t test
and SAM. The relative ranking of the methods was
comparable with our results (several methods tested
here were not published then). In the original Limma
paper [7], among other results, the authors showed that
Limma performs better than the Student t test. This
conclusion was in keeping with our findings. In the ori-
ginal Shrinkage t paper [9] the authors ranked the meth-
ods as follows: Shrinkage t similar but in some cases
better than Limma better than Student better than
SAM. For us, SAM performs better than Student, but
not as well as the Shrinkage t and Limma.
Finally, in Berger’s paper [3], we showed an advantage
for methods adapted to better estimate variance, and in
particular for the methods using a window to define the
target genes. Here, we show that the Window t test and
Regularized t test perform equivalently, however not as
well as the Shrinkage t and better than Limma, except
notably when the number of replicates is two.
All of the previously published results are in accor-
dance with the results presented here, as we show that
the methods based on either shrinkage of the window
variance estimator (Shrinkage t test, Regularized t test
and Window t test) provide the best performance. How-
ever, we can affirm that our results are more representa-
tive since they were obtained from analysis of actual
biological data.
As pointed out in a recent reanalysis of the Golden
Spike experiment [12], spike-in datasets available to
date, while valuable, either contain too few DEGs, or are
flawed by several artifacts, such as unrealistically high
concentrations of DEGs. In conclusion, the authors
encouraged the creation of new spike-in datasets in
order to complete and improve the method for bench-
marking of DEG analysis of Affymetrix assays. Such
datasets should have the following characteristics: (1) a
realistic spike-in concentration, (2) a mixture of up- and
down-regulated genes, (3), unrelated fold change and
intensity, and (4) a large number of arrays.
Here, we propose a dataset that is not a spike-in data-
set, though we believe that it meets the conditions stipu-
lated in the article by Pearson.
Several studies (e.g. [2,3]) on differential expression
analysis have postulated a complex relationship between
variability and expression level. In some methodologies
[2,3,5], this empirical relationship was used to improve
the assessment of variance in a statistical framework.
Spike-in and simulated datasets do not take this empiri-
cal relationship into account, compared with the biologi-
cal benchmark described in this paper. The relationship
found in our data (figure 2) reveals that the design of
our biological benchmark from real datasets leads to a
similar expression level/variability dependence compared
with real datasets.
Many factors can influence the variability of expres-
sion of probesets, from technical sources to biological
properties, and simulation of realistic variance compo-
nents is not completely straightforward. Genes present
both shared and diverging properties. In this context,
creation of a benchmark dataset from a repository of
biological datasets preserves individual variability
properties, as no assumptions on individual variance
are needed during the creation of the benchmark data-
set. Each potential source of variation is retrieved from
real data, thus retaining the contributions from
sources of variability, without the need to quantify or
list them.
The MAplots of our datasets show that the genes
which we defined as DEGs are present at all concentra-
tions, with variable fold change (1) and meeting point
(3). Selected genes were shown to be a mixture of up-
and down-regulated genes, meeting point (2). Finally, we
performed analyses using a number of replicates going
from ten to two by condition, meeting point (4).
We have shown with the mean versus standard devia-
tion relationship, MAplots and volcano plots that the
datasets we built are closer to real datasets in terms of
expression and fold-change distribution, than those of
spike-in datasets such as the Latin Square HGU95 and
HGU133a from Affymetrix or Choe’s Golden Spike
Experiment. Moreover, the resulting dataset contains
biological as well as technical variability and we have
shown that it is representative of the mean-variance
relationship of real datasets.
ROC curves were only used in this work to generate
the data used to construct figures 5 and 6. We used the
values for a FPR equal to the prevalence, as, above this
limit, the number of false negative exceeds the number
of positives (see additional file 1 for details).
These figures present the core benchmarking results.
They reveal that, among the methods tested, the Shrink-
age t test performs best under all conditions (number of
replicates and difficulty to find the truth), although
De Hertogh et al. BMC Bioinformatics 2010, 11:17
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Regularized t test and Window t test show slightly bet-
ter performances and when the number of replicates is
high (≤ 10), the choice of the method has a lower
impact on performance. The reason why the Shrinkage t
does not perform well for two replicates is that it does
not rely on a pre-defined distributional model. This
implies that it needs several replicates to assess this dis-
tribution. The fact that the Window t test and Regular-
ized t test take the number of replicates into account in
the statistic calculation is the reason why they perform
better when the number of replicates is low.
We then computed the absolute performances of three
methods. The results presented in figure 7, although
limited to one-color arrays under GCRMA as pre-treat-
ment, confirm the trends which we suggested with rela-
tive results (figure 5 and 6). Keeping in mind that, in
some pathways, even slight differences in gene expres-
sion can lead to dramatic changes in terms of metabolic
effects, one should be aware that the methods tested
here, although among the best available today, could
still be greatly improved.
One could thus raise the question as to the reliability
of the results when the number of replicates is low. One
way to address this issue would be to adapt the methods
to better estimate variance when the number of repli-
cates is low. Another way would be to perform statisti-
cal analysis on relevant groups of genes rather than on
isolated genes. The design of relevant groups of genes
still remains a challenge.
Conclusions
The benchmark method proposed here differs from
other approaches published, as actual biological and
Figure 7 Absolute performances of the methods. Absolute sensitivity versus number of replicates for classic Student’s t test, Shrinkage t and
Regularized t test. From a to d: Runs 1 to 4 (DEGs increasingly difficult to find). As previously commented, the Shrinkage t performs best overall,
except for 2 replicates.
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Mean - Standard deviation relationships and MAplots
confirm that the variance structure of the data we stu-
died is closer to biological data than that of spike-in
or simulation studies. One other advantage of the
method lies in the fact that virtually all parameters
can be fine-tuned, allowing researchers to assess those
methods which are truly suited for their particular
approaches.
We applied the benchmark to a set of published
methods. The results show better performances for the
Shrinkage t test, except when there are only two repli-
cates, where the Regularized t test and Window t test
perform better.
Perspectives
In order to compare all the analytical methods, includ-
ing pretreatments, we also plan to modify the way in
which the truth is defined in our DB matrix, for exam-
ple using an in silico spike-in procedure and finding a
way to preserve the biological variances associated with
the DB-probesets. However this constraint is not trivial
to circumvent.
In this study, we only work with GCRMA as the pre-
treatment, with a prevalence of 1%. Some authors [26]
show that correlations between probesets can also influ-
ence performances of the statistical methods, namely
favoring the Shrinkage t and Limma. In the future, our
work will concentrate on an exhaustive study of the
nested effects of those three parameters (pretreatment,
prevalence and correlation), but is outside the scope of
this paper due to its complexity. In the same way, we
could improve the way we present the results by using a
classification based on the level of expression for
example.
Additional file 1: Supplementary data. Parameterization. ROC curve
analysis details. Figures 5, 6 and 7 with error bars. Calculation of the
number of rows used throughout all the analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2105-11-
17-S1.DOC]
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